Ethical challenges posed by clinical progress in AIDS

Bayer and Stryker discuss the ethics concerning access to care for AIDS patients, drug therapy compliance, and drug resistance.

Saved in:
Bibliographic Details
Published in:American journal of public health (1971) 1997-10, Vol.87 (10), p.1599-1602
Main Authors: Bayer, R, Stryker, J
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
Acquired immunodeficiency syndrome
Acquired Immunodeficiency Syndrome - drug therapy
Acquired Immunodeficiency Syndrome - economics
AIDS
AIDS/HIV
Ambulatory care
Anti-HIV Agents - economics
Anti-HIV Agents - therapeutic use
Bioethics
Clinical management
Cost control
Drug resistance
Drug therapy
Ethical dilemmas
Ethics
Ethics, Medical
Federal Government
Health care access
Health care expenditures
Health care policy
Health Services Accessibility - economics
HIV
Human immunodeficiency virus
Humans
Insurance, Health
Medicaid
Medical ethics
Paternalism
Patient Compliance
Patients
Personal Autonomy
Prescription drugs
Progress
Protease Inhibitors - economics
Protease Inhibitors - therapeutic use
Public health
Ryan White Comprehensive AIDS Resources Emergency Act 1990-US
Social Justice
United States
USA
Vulnerable Populations
Withholding Treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bayer and Stryker discuss the ethics concerning access to care for AIDS patients, drug therapy compliance, and drug resistance.
ISSN:0090-0036
1541-0048
DOI:10.2105/AJPH.87.10.1599